Tri Cell Therapeutics Private Limited, a struck off private limited company, was established on 15 June 2007 in Chennai, Tamil Nadu, India. Engaging in preventive health services within the healthcare sector, it holds CIN: U85100TN2007PTC063975. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹6.50 Cr and a paid-up capital of ₹6.29 Cr.
Its leadership includes Abhaya Kumar Srisrimal (Director), Venkatachalam Venkatachalapathy Ramasamyudayar (Director), Ramamurthy Thyagarajan (Director). Past directors included Abhaya Kumar Srisrimal, Venkatachalam Venkatachalapathy Ramasamyudayar, Ramamurthy Thyagarajan. Its latest AGM occurred on 30 September 2013, with the balance sheet filed on 31 March 2013. It is based at No.26, Vandalur Kelambakkam Main Road, Keelakottaiyur, Chennai, Tamil Nadu, 600048.
U85100TN2007PTC063975
063975
15 June 2007
₹6.50 Cr
₹6.29 Cr
Roc Chennai
Unlisted
Struck Off
Explore comprehensive insights into Tri Cell Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhaya Kumar Srisrimal | Director | 03 Dec 2007 | Current |
| Venkatachalam Venkatachalapathy Ramasamyudayar | Director | 03 Dec 2007 | Current |
| Ramamurthy Thyagarajan | Director | 03 Dec 2007 | Current |
| Vallavanur Subramaniam Pattabiraman | Director | 15 Jun 2007 | Current |
| Jayarama Ramanan | Director | 15 Jun 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Tri Cell Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Tri Cell Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Tri Cell Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Tri Cell Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tri Cell Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Tri Cell Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2013 as per latest MCA records. was documented.
Tri Cell Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Chennai. was recorded as a recent event.
Progress on Abhaya Kumar Srisrimal was appointed as a Director was appointed as a Director on 03 Dec 2007 & has been associated with this company since 17 years 11 months . was documented.
Progress on Venkatachalam Venkatachalapathy Ramasamyudayar was appointed as a Director was appointed as a Director on 03 Dec 2007 & has been associated with this company since 17 years 11 months . was documented.
The activity Ramamurthy Thyagarajan was appointed as a Director was appointed as a Director on 03 Dec 2007 & has been associated with this company since 17 years 11 months . was completed.
The activity Vallavanur Subramaniam Pattabiraman was appointed as a Director was appointed as a Director on 15 Jun 2007 & has been associated with this company since 18 years 5 months . was completed.
LifeCell: First cord blood bank to screen for diseases and cancer. India's pioneer in the game. #innovative #savinglives #humblebrag.
The CIN of Tri Cell Therapeutics Private Limited is U85100TN2007PTC063975.
Tri Cell Therapeutics Private Limited is headquartered at No.26, Vandalur Kelambakkam Main Road, Keelakottaiyur, Chennai, Tamil Nadu, 600048.
Tri Cell Therapeutics Private Limited was incorporated on 15 June 2007.
The current directors of Tri Cell Therapeutics Private Limited are
The primary industry of Tri Cell Therapeutics Private Limited is Healthcare.
Tri Cell Therapeutics Private Limited is unlisted.
The authorized capital of Tri Cell Therapeutics Private Limited is ₹6.50 Cr, and the paid-up capital is ₹6.29 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX